Skip to content

All Press Releases

CEO Gustav H. Gram increases holding in PILA PHARMA AB

Malmö, 02 September 2024 Pila Pharma AB (publ) (FN STO: PILA) announces that recently appointed CEO Gustav H. Gram has purchased additional shares. The purchases occurred on Wednesday, 30 August, where 29.375 shares in the company were acquired. The shares were purchased at an average price of SEK 5,1768.___Mr. Gram's direct holdings in Pila Pharma AB now amounts to 74.816 shares.CEO Gustav H…

Read more

PILA PHARMA publishes interim report (1 January – 30 June 2024)

Malmö, 27 August, 2024 PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s interim report for the period January - June 2024. The report can be found on the Company´s website: https://pilapharma.com/investors/finansiell-information/ SUMMARY OF INTERIM REPORT First Half year (1 January - 30 June 2024) Operating income amounted to TSEK 683 (1 097) The operating result (EBIT) totalled to…

Read more

PILA PHARMA INVITES TO INVESTOR Q&A & PRESENTATIONS

Malmö, August 26, 2024 PILA PHARMA AB (publ) (FN STO: PILA) hereby invites interested investors to participate in our scheduled events in the coming week:___________Stokk.io Online Webinar - H2 Report (ONLINE)Tuesday, August 27, 2024 from 12:00 CET Malmö, August 26, 2024 Aktiespararna Online Life Science Day (ONLINE)Wednesday, August 28, 2024 from 20:00 CETRedeye Online Investor Event (ONLINE)Thursday, August 29, 2024 from…

Read more

Contact us

Subscription for press releases
Back To Top